Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Acta Otorrinolaringol Esp (Engl Ed)
; 73(2): 82-88, 2022.
Article
in En
| MEDLINE
| ID: mdl-35397828
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Papilloma
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Child
/
Humans
Language:
En
Journal:
Acta Otorrinolaringol Esp (Engl Ed)
Year:
2022
Type:
Article